FDA Reports on Risk of Lymphoma from Breast Implants MINDY WAIZER Thursday, March 22, 2018 Although occurrence is rare, individuals who undergo breast implantation have an increased risk of developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)–a type of non-Hodgkin’s lymphoma. Since this disease is not well-studied yet, the Food and Drug Administration (FDA) has provided medical device reports (MDRs), also known as adverse events … Continue reading The connection between breast implants and cancer